Invited Speakers SASAT 2008
- A. Nicolaides (Cyprus) - IUA Consensus on DVT and LMWHs
- R. Kennedy (USA) - Generic Equivalence Today
- R. Hull (Canada) - Clinical Differentiation of LMWHs
- W. Leong (Canada) - ACCP - s Position
- W. Haque (Canada) - Bioequivalence of Complex Drugs
- G. Rao (USA) - Generic Antithrombotic Drugs in India
- J. Fareed (USA) - Are Current Guidelines Valid?
- R. Wahi (USA) - A Clinicians Perspective
- W. Raake (Germany) - EMEA and USFDAs Position
- F. Ofosu (Canada) - Issues on Heparins
- E. Ramacciotti (Brazil/USA) - Immunogenic Inequivalence
- R. Saxena (India) - HIT and Generic LMWHs
- E. Kalodiki (UK) - IUA Whitepaper
- B. K. Rao (India) - Cost Factors
- O. Iqbal (USA) - Anticoagulant Effects of Generic LMWHs
- J. Harenberg (Germany) - Report of the ADHOC Group of the ISTH
- M. Ahluwalia (USA) - Contaminants in Heparins
- V. Arora (India) - A surgeons perspective
- D. Van Thiel (USA) - Safety issues
- L. Pathak (India) - Cardiovascular implications
- P. Aggarwal (USA) - FDA compliance issues
Additional topics will be included in the final program. This Summit will
also discuss the white paper based on the 2007-2008 Summit.
Conference Scope -
Scientific Program -
Invited Speakers -
Awards & Arrangements
|